Sphingosylphosphorylchloline

Sphingosylphosphorylchloline

SCHEMBL12513601

CCCCCCCCCCCCC/C=C/C(O)C(N)COP(=O)(O)OCC[N+](C)(C)C

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.78
KMT2A Q03164 4/20 0.78
S1PR1 P21453 3/20 0.78
S1PR4 O95977 2/20 0.69
S1PR3 Q99500 2/20 0.69
S1PR5 Q9H228 2/20 0.69
ALDH1A1 P00352 2/20 0.69
S1PR2 O95136 1/20 0.69
TSPO P30536 1/20 0.69
TMEM97 Q5BJF2 1/20 0.69
SIGMAR1 Q99720 1/20 0.69
SMPD1 P17405 1/20 0.50
P2RY10 O00398 5/20 0.49
MAPT P10636 3/20 0.49
GMNN O75496 2/20 0.49
LMNA P02545 2/20 0.49
GLA P06280 2/20 0.49
POLB P06746 2/20 0.49
THRB P10828 2/20 0.49
CETP P11597 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sphingosylphosphorylchloline SCHEMBL196365 1.00 MEN1 (0.78) MEN1KMT2AS1PR1S1PR4S1PR3
Sphingosylphosphorylchloline SCHEMBL196291 0.99 MEN1 (0.77) MEN1KMT2AS1PR1S1PR4S1PR3
Sphingosylphosphorylchloline SCHEMBL195873 0.99 MEN1 (0.77) MEN1KMT2AS1PR1S1PR4S1PR3
SCHEMBL17696724 0.90 S1PR1 (0.77) MEN1KMT2AS1PR1S1PR4S1PR3
SCHEMBL17775054 0.88 S1PR1 (0.62) MEN1KMT2AS1PR1S1PR4S1PR3
Sphingosylphosphorylchloline SCHEMBL195431 0.88 S1PR1 (1.00) MEN1KMT2AS1PR1S1PR4S1PR3
Sphingosylphosphorylchloline SCHEMBL19928025 0.88 S1PR1 (1.00) MEN1KMT2AS1PR1S1PR4S1PR3
SCHEMBL31427625 0.88 S1PR1 (1.00) MEN1KMT2AS1PR1S1PR4S1PR3
SCHEMBL29602895 0.87 S1PR1 (0.73) MEN1KMT2AS1PR1S1PR4S1PR3
SCHEMBL14095793 0.85 S1PR1 (0.58) MEN1KMT2AS1PR1S1PR4S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2011-07-21 US disclosed
WO-2009064696-A1 STEROL-MODIFIED AMPHIPHILIC LIPIDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177156-A1 Sterol-Modified Amphiphilic Lipids SREBF1, SREBF2, SGMS1 MEN1 1960/4885KMT2A 4672/4885S1PR1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.